» Articles » PMID: 18095988

Expression of HuR in Merkel Cell Carcinoma and in Normal Skin

Overview
Journal J Cutan Pathol
Publisher Wiley
Specialty Dermatology
Date 2007 Dec 22
PMID 18095988
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: HuR is a ubiquitously expressed member of the Elav/Hu family of mRNA-binding proteins, and its cytoplasmic expression has been recognised to participate in carcinogenesis. The aims of this study were to explore the expression pattern of HuR in primary Merkel cell carcinoma (MCC), lymph node metastases and non-neoplastic skin.

Methods: Twenty-two primary MCC samples and five lymph node metastases were evaluated for HuR expression by immunohistochemistry. The data were compared with clinical parameters.

Results: Nuclear and cytoplasmic HuR-staining patterns were observed. Nuclear immunoreactivity was observed in 91% of the primary tumors and in 80% of the lymph node metastases. Cytoplasm was positive in 27% of the primary tumors and in 60% of the lymph node metastases. No cytoplasmic HuR immunoreactivity was detected in non-neoplastic skin. However, moderate to strong nuclear staining was found in normal epidermis and in the epithelium of hair follicles and sebaceous glands. Expression of HuR in MCC did not associate with clinicopathological parameters.

Conclusions: Primary MCCs and their lymph node metastases as well as non-neoplastic skin show nuclear expression of HuR protein. In contrast to non-neoplastic skin, a subset of MCC tumors show cytoplasmic HuR staining, which may contribute to carcinogenesis in MCC.

Citing Articles

Gene expression profile identifies distinct molecular subtypes and potential therapeutic genes in Merkel cell carcinoma.

Saddozai U, Wang F, Cheng Y, Lu Z, Akbar M, Zhu W Transl Oncol. 2020; 13(11):100816.

PMID: 32771971 PMC: 7412862. DOI: 10.1016/j.tranon.2020.100816.


Multiple functions of HuR in urinary tumors.

Zhang F, Cai Z, Lv H, Li W, Liang M, Wei X J Cancer Res Clin Oncol. 2018; 145(1):11-18.

PMID: 30370480 DOI: 10.1007/s00432-018-2778-2.


HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells.

Muralidharan R, Mehta M, Ahmed R, Roy S, Xu L, Aube J Sci Rep. 2017; 7(1):9694.

PMID: 28855578 PMC: 5577245. DOI: 10.1038/s41598-017-07787-4.


HuR Small-Molecule Inhibitor Elicits Differential Effects in Adenomatosis Polyposis and Colorectal Carcinogenesis.

Lang M, Berry D, Passecker K, Mesteri I, Bhuju S, Ebner F Cancer Res. 2017; 77(9):2424-2438.

PMID: 28428272 PMC: 5826591. DOI: 10.1158/0008-5472.CAN-15-1726.


Clinical significance of HuR expression in human malignancy.

Kotta-Loizou I, Giaginis C, Theocharis S Med Oncol. 2014; 31(9):161.

PMID: 25112469 DOI: 10.1007/s12032-014-0161-y.